Usefulness of age-specific reference range of prostate-specific antigen for japanese men older than 60 years in mass screening for prostate cancer

Urology

Volumn 56, Issue 2, 2000, Pages 278-282

  Ito, Kazuto ^a   Yamamoto, Takumi ^a   Kubota, Yutaka ^a   Suzuki, Kazuhiro ^a   Fukabori, Yoshitatsu ^a   Kurokawa, Kohei ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CONTACT EXAMINATION; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; MASS SCREENING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; STANDARD; STATISTICS; TRANSRECTAL ULTRASONOGRAPHY;

AGE DISTRIBUTION; AGED; BIOPSY; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 0033926763     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00613-0     Document Type: Article

References (16)

1. Ito K., Kubota Y., Banzai R., et al. The present status, problems, and future of mass screening for prostate cancer in Gunma Prefecture the report of mass screening for prostate cancer study meeting in 1998 . Kitakanto Med J. 49:1999;81-88.
2. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men establishment of age-specific reference ranges . JAMA. 270:1993;860-864.
3. DeAntoni E.P., Crawford E.D., Oesterling J.E., et al. Age-and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology. 48:1996;234-239.
4. Anderson J.R., Strickland D., Corbin D., et al. Age-specific reference ranges for serum prostate-specific antigen. Urology. 46:1995;54-57.
5. Oesterling J.E., Kumamoto Y., Tsukamoto T., et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men lower values than for similarly aged white men . Br J Urol. 75:1995;347-353.
6. El-Galley R.E.S., Petros J.A., Sanders W.H., et al. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma. Urology. 46:1995;200-204.
7. Catalona W.J., Hudson M.A., Sardino P.T., et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:1994;2037-2042.
8. Dalkin B.L., Ahmann F.R., Kopp J.B., et al. Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostate carcinoma. Br J Urol. 76:1995;346-350.
9. Etzioni R., Shen Y., Jason C., et al. Age-specific prostate-specific antigen a reassessment . Prostate. 7:1996;70-77.
10. Bassler T.J., Orozco R., Bassler I.C., et al. Most prostate cancer missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant. Urology. 52:1998;1064-1069.
11. Partin A.W., Criley S.R., Subong E.N., et al. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer a pathological analysis . J Urol. 155:1996;1336-1339.
12. Paul R., Breul J., Hartung R. Prostate-specific antigen density and age-specific prostate-specific antigen values the solution of prostate cancer screening . Eur Urol. 27:1995;286-291.
13. Morgan T.O., Jacobsen S.J., McCarthy W.F., et al. Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med. 335:1996;304-310.
14. Lin W.Y., Gu C.J., Kao C.H., et al. Serum prostate-specific antigen in healthy Chinese men establishment of age-specific reference ranges . Neoplasma. 43:1996;103-105.
15. Oesterling J.E., Jacobsen S.J., Cooner W.H. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J Urol. 153:1995;1160-1163.
16. Borer J.G., Sherman J., Solomon M.C., et al. Age specific prostate specific antigen reference ranges population specific . J Urol. 159:1998;444-448.